Cargando…

Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients

INTRODUCTION: Fibrosis is an inevitable complication of chronic hepatitis C virus (HCV) infection. Direct acting antivirals (DAAs) radically treated HCV and were suggested to ameliorate fibrosis. Silymarin (a natural herbal remedy) was proposed to further decrease hepatic inflammation and fibrosis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rewisha, Eman, Salman, Tary, Alhaddad, Omkolsoum, Raia, Gamal Abo, Naguib, Mary, Rashad, Shymaa, Abdelfattah, Ahmed, Metwally, Khaled, Abdelsameea, Eman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527342/ https://www.ncbi.nlm.nih.gov/pubmed/34712835 http://dx.doi.org/10.5114/ceh.2021.109293

Ejemplares similares

The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction
por: Elsabaawy, Maha Mohammad, et al.
Publicado: (2015)

Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease
por: Alhaddad, Omkolsoum Mohamed, et al.
Publicado: (2015)

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
por: Salman, Tary, et al.
Publicado: (2021)

Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites
por: Metwally, Khaled, et al.
Publicado: (2018)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
por: Hassany, Sahar M, et al.
Publicado: (2020)

Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C
por: Naguib, Mary, et al.
Publicado: (2022)

Epidermal growth factor rs4444903 polymorphism and risk of cholangiocarcinoma. A case control study
por: Gawish, Eman Ahmed, et al.
Publicado: (2023)

The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients
por: Raia, Gamal Y. S., et al.
Publicado: (2022)

Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt
por: Alhaddad, Omkolthoum, et al.
Publicado: (2020)

Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods
por: Abdalla, Ahmed F, et al.
Publicado: (2009)

A case report of COVID-19 evoked cholangitic liver abscess
por: Alhaddad, Omkolsoum, et al.
Publicado: (2022)

Intermediate stage hepatocellular carcinoma: a summary review
por: Elshaarawy, Omar, et al.
Publicado: (2019)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
por: El Kassas, Mohamed, et al.
Publicado: (2020)

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Study of the association between a MICA gene polymorphism and cholangiocarcinoma in Egyptian patients
por: Abdel-Rahman, Adel A.-H., et al.
Publicado: (2022)

Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C
por: Pan, Jason J., et al.
Publicado: (2018)

Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
por: Niu, Bin, et al.
Publicado: (2023)

A151 OSEPHAGEAL VARICEAL RECURRENCE 4 YEARS BEYOND ENDOSCOPIC BAND LIGATION IN HEPATITIS C PATIENTS WHO ACHIEVED SUSTAINED VIROLOGICAL RESPONSE WITH ORAL DIRECT ACTING ANTIVIRAL THERAPIES
por: Abdel-Samiee, M, et al.
Publicado: (2023)

The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Hassona, Mona M, et al.
Publicado: (2021)

XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population
por: Naguib, Mary, et al.
Publicado: (2020)

Bacteriological and serological investigation of Clostridium perfringens in lambs
por: Moustafa, Shymaa, et al.
Publicado: (2022)

The effect of intravenous infusion of N-acetyl cysteine in cirrhotic patients undergoing liver resection: A randomized controlled trial
por: Sayed, Eman, et al.
Publicado: (2017)

Evaluation of Amino Acids Profile as Non-Invasive Biomarkers of Hepatocellular Carcinoma in Egyptians
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2022)

Hepatitis C Virus Infection in Eastern Libya: Efforts Needed to Improve HCV Testing and Linkage to Care in the Resource-Limited Setting
por: Ismail, Faisal, et al.
Publicado: (2022)

Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients
por: Abdelsameea, Eman, et al.
Publicado: (2020)

Rapid Dissemination followed by Spontaneous Regression of Metastatic Hepatocellular Carcinoma after Liver Radiofrequency Thermal Ablation: A Case Report with Correlative Immune Assay
por: Xu, Yiqing, et al.
Publicado: (2023)

Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2020)

Cancer incidence in the Tobruk area, eastern Libya: first results from Tobruk Medical Centre
por: Ismail, Faisal, et al.
Publicado: (2021)

Fibrosis regression following hepatitis C antiviral therapy
por: Elsharkawy, Aisha, et al.
Publicado: (2022)

Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes
por: Piedade, Juliana, et al.
Publicado: (2021)

Exploring the applications of hyaluronic acid‐based nanoparticles for diagnosis and treatment of bacterial infections
por: Mohammed, Mahir, et al.
Publicado: (2022)

Serum Hyaluronic Acid: A Promising Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Shiha, Gamal
Publicado: (2008)

Thyroid Dysfunction and Renal Function: A Crucial Relationship to Recognize
por: Naguib, Rania, et al.
Publicado: (2023)

Serum Ghrelin Concentration in Patients With Primary Biliary Cirrhosis (PBC)
por: Naguib, Rania, et al.
Publicado: (2021)

Host pharmacogenetic factors that may affect liver neoplasm incidence upon using direct-acting antivirals for treating hepatitis C infection
por: Zidan, Ahmad M., et al.
Publicado: (2021)

Correction to: Isolation, characterization, and application of lytic bacteriophages for controlling Enterobacter cloacae complex (ECC) in pasteurized milk and yogurt
por: Nasr-Eldin, Mohamed A., et al.
Publicado: (2023)

Isolation, characterization, and application of lytic bacteriophages for controlling Enterobacter cloacae complex (ECC) in pasteurized milk and yogurt
por: Nasr-Eldin, Mohamed A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k907to00d3q6kcvsv2324b9nli